14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 ACOR stock ended at $0.661. During the day the stock fluctuated 0% from a day low at $0.661 to a day high of $0.661.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Acorda Therapeutics prices

Date Open High Low Close Volume
Nov 22, 2016 $20.75 $21.60 $20.55 $20.80 825 470
Nov 21, 2016 $19.75 $20.65 $19.50 $20.40 927 240
Nov 18, 2016 $21.25 $21.60 $21.10 $21.30 423 279
Nov 17, 2016 $20.35 $21.25 $19.50 $21.25 429 890
Nov 16, 2016 $20.65 $20.77 $20.20 $20.40 365 430
Nov 15, 2016 $21.40 $21.40 $20.55 $20.85 410 835
Nov 14, 2016 $20.90 $21.65 $20.70 $21.40 472 729
Nov 11, 2016 $20.45 $21.10 $20.00 $20.75 504 799
Nov 10, 2016 $20.10 $20.95 $20.10 $20.60 1 140 511
Nov 09, 2016 $19.05 $20.40 $18.32 $19.95 792 188
Nov 08, 2016 $18.00 $18.00 $18.00 $18.00 359 748
Nov 07, 2016 $17.80 $17.80 $17.80 $17.80 429 400
Nov 04, 2016 $16.90 $16.90 $16.90 $16.90 706 700
Nov 03, 2016 $16.45 $16.45 $16.45 $16.45 733 700
Nov 02, 2016 $17.55 $17.55 $17.55 $17.55 578 500
Nov 01, 2016 $17.75 $17.75 $17.75 $17.75 666 600
Oct 31, 2016 $17.70 $17.70 $17.70 $17.70 576 400
Oct 28, 2016 $17.70 $17.70 $17.70 $17.70 883 100
Oct 27, 2016 $18.25 $18.25 $18.25 $18.25 671 700
Oct 26, 2016 $19.75 $19.75 $19.75 $19.75 625 100
Oct 25, 2016 $19.60 $19.60 $19.60 $19.60 355 000
Oct 24, 2016 $20.10 $20.10 $20.10 $20.10 384 300
Oct 21, 2016 $20.10 $20.10 $20.10 $20.10 344 200
Oct 20, 2016 $20.20 $20.20 $20.20 $20.20 435 800
Oct 19, 2016 $20.05 $20.05 $20.05 $20.05 409 300
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT